跳至主要内容
临床试验/NCT06499701
NCT06499701招募中不适用

Volume Kinetics of Fluid Resuscitation With 30 ml/kg Ringer Lactate in Early Sepsis

Institutul de Urgenţă pentru Boli Cardiovasculare Prof.Dr. C.C. Iliescu2 个研究点 分布在 1 个国家目标入组 15 人开始时间: 2024年6月19日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
15
试验地点
2
主要终点
Plasma Volume

研究概览

简要总结

The recommended volume resuscitation for patients with early sepsis-induced hypoperfusion is at least 30 ml/kg of crystalloid administered within the first three hours. However, this standardized approach does not account for individual patient variability and lacks personalization. Additionally, the effects of administering 30 ml/kg on intercompartmental fluid shifts between the plasma and interstitial compartments remain unclear. This study aims to describe the volume kinetics of administering 30 ml/kg of Ringer's Lactate in patients with early sepsis-induced hypoperfusion within the first three hours.

详细描述

Adult patients admitted to the intensive care unit (ICU) with sepsis, as defined by the Sepsis-3 criteria, and exhibiting sepsis-induced hypoperfusion prior to receiving adequate volume resuscitation (i.e., 30 ml/kg of crystalloid), are administered Ringer's Lactate at a dose of 30 ml/kg. The initial 20 ml/kg is infused at a constant rate over the first 30 minutes, followed by a 30-minute pause, with an additional 10 ml/kg administered over the subsequent 15 minutes, completing the infusion within 75 minutes.

Up to 180 minutes post-infusion, no other fluids (e.g., gelatin, albumin) are administered except for antibiotics, sedatives, or vasoactive substances as needed. Ideally, only one catecholamine (e.g., norepinephrine) is administered. The volume and quantity of these substances are recorded. Arterial blood samples are collected for blood gas analysis, including hemoglobin levels. Urinary output is measured at 30, 60, and 180 minutes, and any blood loss, other than the 1.5 ml per sample collected, is quantified during hemoglobin monitoring. Additionally, urinary creatinine concentration is determined from urine samples collected at baseline.

The hemodilution data are utilized as input into a three-compartment model with microconstants for fluid redistribution and excretion.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • A diagnosis of sepsis, as defined by the Sepsis-3 criteria and exhibiting sepsis-induced hypoperfusion prior to the administration of adequate volume resuscitation:
  • hypotension requiring norepinephrine to maintain a mean arterial blood pressure (MAP) either predefined by the clinician or at 65 mm Hg or higher and/or
  • a serum lactate level >2 mmol/L (18mg/dL) and/or
  • acute oliguria defined as urine output <0.5mL/kg/hr and/or
  • mottled skin and/or
  • capillary refill time > 3 seconds.

排除标准

  • Administration of at least 1 L of IV fluid in the last 6 hours prior to screening. All crystalloids, colloids and blood products that the patient has received are counted.
  • Known pregnancy.
  • Competing causes of lactic acidosis including: seizures within 3 hours of enrollment, use of linezolid or metformin or anti-retrovirals at the time of enrollment, carbon monoxide or cyanide poisoning, highly suspected or known ischemic bowel, and known mitochondrial disorders.
  • End-stage renal disease that requires chronic dialysis.
  • Concurrent haemorrhagic or obstructive shock.
  • Increased risk of fluid intolerance:
  • Echocardiographic evidence of moderate or severe left ventricular systolic dysfunction.
  • Echocardiographic evidence of moderate or severe right ventricular systolic dysfunction.
  • Hypoxemia index < 200 mmHg or sonographic evidence of bilateral B or C profile.
  • Abdominal compartment syndrome.
  • Post-cardiac arrest.

研究组 & 干预措施

Ringer's Lactate

Adult patients admitted in the intensive care unit (ICU) with sepsis, as defined by the Sepsis-3 criteria and exhibiting sepsis-induced hypoperfusion prior to the administration of adequate volume resuscitation (i.e., 30 ml/kg crystalloid).

干预措施: Ringer's Lactate (Drug)

结局指标

主要结局

Plasma Volume

时间窗: 180 minutes after the start of the Ringer's Lactate infusion

Plasma volume (ml) was determined using a three-compartment kinetic model with five rate constants (k12, k21, k23, k32 and k10) and a scaling factor (Vc, central volume) that relates dilution to volume. This model was applied to the dependent variables, which included frequently measured plasma dilution and urinary excretion.

次要结局

未报告次要终点

研究者

发起方
Institutul de Urgenţă pentru Boli Cardiovasculare Prof.Dr. C.C. Iliescu
申办方类型
Other
责任方
Principal Investigator
主要研究者

Balan Ion Cosmin

Principal Investigator

Institutul de Urgenţă pentru Boli Cardiovasculare Prof.Dr. C.C. Iliescu

研究点 (2)

Loading locations...

相似试验